There are actually rare post-marketing reports of cases of intestinal obstruction, and exacerbation of diverticulitis, some of which have needed health care intervention to get rid of the tablet. Patients with underlying GI Problems which include esophageal cancer or colon cancer with a little gastrointestinal lumen are at increased hazard of acqui